Skip to Content

Join the 'Aspergillosis' group to help and get support from people like you.

Aspergillosis News

FDA Approves Cresemba (isavuconazonium sulfate) For Fungal Infections

Posted 6 Mar 2015 by Drugs.com

March 6, 2015 – The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections. Aspergillosis is a fungal infection caused by Aspergillus species, and mucormycosis is caused by the Mucorales fungi. These infections occur most often in ...

FDA Approves Merck’s Noxafil Delayed-Release Tablets

Posted 26 Nov 2013 by Drugs.com

WHITEHOUSE STATION, N.J., Nov. 26, 2013--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Noxafil (posaconazole) 100 mg delayed-release tablets. Noxafil delayed-release tablets are a new formulation with a loading dose of 300 mg (three 100 mg delayed-release tablets) twice daily on the first ...

Ask a Question

Further Information

Related Condition Support Groups

Aspergillosis - Invasive, Aspergillosis - Aspergilloma, Aspergillosis - Meningitis, Aspergillosis - Meningitis with 5-FC, Systemic Fungal Infection